Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
INTS

INTS - Intensity Therapeutics, Inc Stock Price, Fair Value and News

$6.84-0.58 (-7.82%)
Market Closed

Price Targets

INTS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INTS Price Action

Last 7 days

-14.0%

Last 30 days

-26.8%

Last 90 days

-41.8%

Trailing 12 Months

-88.2%

INTS RSI Chart

INTS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INTS Valuation

Market Cap

16.4M

Price/Earnings (Trailing)

-1.4

Price/Free Cashflow

-1.73

INTS Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

INTS Fundamentals

INTS Earnings

Earnings (TTM)

-11.7M

Earnings Growth (Yr)

23.97%

Earnings Growth (Qtr)

-5.28%

INTS Profitability

Return on Equity

-162.5%

Return on Assets

-122.44%

Free Cashflow Yield

-57.81%

INTS Investor Care

Shares Dilution (1Y)

333.13%

Diluted EPS (TTM)

-15.75

About Intensity Therapeutics, Inc

INTS
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.
0
 CEO
 WEBSITEhttps://intensitytherapeutics.com
 SECTORHealthcare
 INDUSTRYBiotechnology

Intensity Therapeutics, Inc Frequently Asked Questions

INTS is the stock ticker symbol of Intensity Therapeutics, Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Intensity Therapeutics, Inc is 16.43 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.